The brief viability of organs creates a logistical nightmare. Surgeons fly on chartered jets to retrieve organs, while recipients must remain within a small radius of the hospital, unable to travel. Cryopreservation's immediate impact would be to remove time as a variable, allowing for scheduled surgeries and a more humane patient experience.

eGenesis prioritizes organs like kidneys and hearts because they show good outcomes in non-human primates and have high physiological similarity to humans. Livers are more challenging due to differences in synthetic function, dictating a different clinical approach (perfusion) instead of direct transplant.

The sci-fi allure of brain implants and embedded chips often overshadows practical alternatives. Ariel Poler argues that most desired functionalities, from interfacing with AI to carrying identification, can be achieved with less invasive external devices like advanced hearables or wearables, questioning the necessity of risky surgical augmentation for healthy individuals.

In a counterintuitive medical choice, some individuals with healthy but underperforming limbs (e.g., a twisted foot) fight to have them amputated. They recognize that a well-designed modern prosthetic can provide more mobility and a better quality of life than their natural, but chronically dysfunctional, anatomy.

Unlike external machines, implanting parts internally triggers the body's powerful defenses. The immune system attacks foreign objects, and blood forms clots around non-native surfaces. These two biological responses are the biggest design hurdles for internal replacement parts, problems that external devices like dialysis machines don't face.

The "replacement strategy" for longevity analogizes the body to a complex machine like an iPhone. It's often impossible to fix a shattered screen (a failing organ), but swapping the part is simple and effective. This reframes the approach to thousands of "incurable" diseases from repair to replacement.

A major unknown was the surgical procedure itself. After four cases, surgeons report that transplanting a pig kidney is remarkably similar to a human-to-human allogeneic transplant. This de-risks the surgical component significantly, with patients often leaving the ICU in one night.

The traditional medical ethos prevents interventions on non-sick patients. This conservative approach may be irrational when low-risk therapies could add decades of healthy life, challenging the fundamental definition of when a doctor should act.

Patients and doctors often prefer integrated, 'natural' solutions like organ transplants over more practical but external machines. This powerful bias for appearing 'normal' and whole can lead them to pursue complex, risky internal solutions, even when external devices might offer a more stable, albeit less convenient, alternative.